MiRNA-218 Targets Lipin-1 and Glucose Transporter Type 4 Genes in 3T3-L1 Cells Treated With Lopinavir/Ritonavir

Overview

Journal Front Pharmacol

Date 2019 May 29

PMID 31133852

Citations 12

Authors

Elena Bresciani

Cecilia Saletti

Nicola Squillace

Laura Rizzi

Laura Molteni

Ramona Meanti

Robert J Omeljaniuk

Giuseppe Biagini

Andrea Gori

Vittorio Locatelli

Antonio Torsello

Affiliations

Soon will be listed here.

Abstract

Metabolic complications represent a common and serious problem associated with HIV infection and combined Antiretroviral Therapy (cART). Alterations in body fat distribution are associated with significantly increased risks of (i) metabolic derangements, (ii) cardiovascular pathologies, and (iii) insulin resistance. A case control study showed that in subcutaneous adipose tissue from HIV-infected patients on cART presenting lipodystrophy (LS), the levels of miRNA-218 were upregulated and those of lipin-1, a putative target gene of miRNA-218, were downregulated compared with HIV-negative subjects. Lipin-1 is one of the most important factors linked to development of LS. Lipin-1, by controlling PPARγ2, regulates the expression of specific genes, such as that of glucose transporter type 4 (GLUT-4), required for maturation and maintenance of adipocytes. To determine whether lopinavir/ritonavir (LPV/RTV) can modulate lipogenesis in adipocytes affecting miRNA-218 and lipin-1 mRNA expression, and to investigate the functional link between miRNA-218 and GLUT-4 mRNA expression. Differentiated 3T3-L1 cells were treated with various combinations of LPV/RTV, followed by measurements of cell viability, lipid accumulation, lipin-1 and GLUT-4 mRNA and miRNA-218 levels. Transfection of anti-miR-218 or a miRNA-218 mimic were used to investigate the role of miRNA-218 in lipogenesis. LPV/RTV treatment of 3T3-L1 cells did not affect the viability of differentiated 3T3-L1 cells, but caused (i) a significant decrease of lipid accumulation, (ii) an overexpression of miRNA-218, and (iii) a reduction of lipin-1 and GLUT-4 mRNA levels. The anti-miR-218 transfection of 3T3-L1 cells significantly ameliorated the adipogenic dysfunction and restored mRNA levels of lipin-1 and GLUT-4 consequent to LPV/RTV treatment. By contrast, 3T3-L1 cells transfected with a specific miRNA-218 mimic showed (i) an overexpression of miRNA-218, (ii) a reduced cellular lipid fraction, and (iii) decreased levels of mRNA for lipin-1 and GLUT-4. 3T3-L1 cells, treated with LPV/RTV, show altered lipid content due to increased miRNA-218 levels, which affects lipin-1 mRNA. Moreover, increased miRNA-218 levels were inversely correlated with changes in GLUT-4 expression, which suggests a role for miRNA-218 in mediating the insulin resistance consequent to cART.

Citing Articles

The role of noncoding RNAs in metabolic reprogramming of cancer cells.

Safi A, Saberiyan M, Sanaei M, Adelian S, Davarani Asl F, Zeinaly M Cell Mol Biol Lett. 2023; 28(1):37.

PMID: 37161350 PMC: 10169341. DOI: 10.1186/s11658-023-00447-8.

Tear Film MicroRNAs as Potential Biomarkers: A Review.

Altman J, Jones G, Ahmed S, Sharma S, Sharma A Int J Mol Sci. 2023; 24(4).

PMID: 36835108 PMC: 9962948. DOI: 10.3390/ijms24043694.

miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis.

Bresciani E, Squillace N, Orsini V, Piolini R, Rizzi L, Molteni L Int J Mol Sci. 2022; 23(7).

PMID: 35408847 PMC: 8998861. DOI: 10.3390/ijms23073486.

A Critical Review of the Biochemical Mechanisms and Epigenetic Modifications in HIV- and Antiretroviral-Induced Metabolic Syndrome.

Mohan J, Ghazi T, Chuturgoon A Int J Mol Sci. 2021; 22(21).

PMID: 34769448 PMC: 8584285. DOI: 10.3390/ijms222112020.

Sirtuins as Interesting Players in the Course of HIV Infection and Comorbidities.

Jurkowska K, Szymanska B, Knysz B, Kuzniarski A, Piwowar A Cells. 2021; 10(10).

PMID: 34685718 PMC: 8534645. DOI: 10.3390/cells10102739.

References

Shepherd P, Kahn B . Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus. N Engl J Med. 1999; 341(4):248-57. DOI: 10.1056/NEJM199907223410406. View

Peterfy M, Phan J, Xu P, Reue K . Lipodystrophy in the fld mouse results from mutation of a new gene encoding a nuclear protein, lipin. Nat Genet. 2001; 27(1):121-4. DOI: 10.1038/83685. View

Holstein A, Plaschke A, Egberts E . Lipodystrophy and metabolic disorders as complication of antiretroviral therapy of HIV infection. Exp Clin Endocrinol Diabetes. 2001; 109(8):389-92. DOI: 10.1055/s-2001-18990. View

Bartel D . MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116(2):281-97. DOI: 10.1016/s0092-8674(04)00045-5. View

Kumar G, Jayanti V, Johnson M, Uchic J, Thomas S, Lee R . Metabolism and disposition of the HIV-1 protease inhibitor lopinavir (ABT-378) given in combination with ritonavir in rats, dogs, and humans. Pharm Res. 2004; 21(9):1622-30. DOI: 10.1023/b:pham.0000041457.64638.8d. View

Parker R, Flint O, Mulvey R, Elosua C, Wang F, Fenderson W . Endoplasmic reticulum stress links dyslipidemia to inhibition of proteasome activity and glucose transport by HIV protease inhibitors. Mol Pharmacol. 2005; 67(6):1909-19. DOI: 10.1124/mol.104.010165. View

Peterfy M, Phan J, Reue K . Alternatively spliced lipin isoforms exhibit distinct expression pattern, subcellular localization, and role in adipogenesis. J Biol Chem. 2005; 280(38):32883-9. DOI: 10.1074/jbc.M503885200. View

Noor M, Flint O, Maa J, Parker R . Effects of atazanavir/ritonavir and lopinavir/ritonavir on glucose uptake and insulin sensitivity: demonstrable differences in vitro and clinically. AIDS. 2006; 20(14):1813-21. DOI: 10.1097/01.aids.0000244200.11006.55. View

van Harmelen V, Ryden M, Sjolin E, Hoffstedt J . A role of lipin in human obesity and insulin resistance: relation to adipocyte glucose transport and GLUT4 expression. J Lipid Res. 2006; 48(1):201-6. DOI: 10.1194/jlr.M600272-JLR200. View

10.

Giralt M, Domingo P, Guallar J, Rodriguez de la Concepcion M, Alegre M, Domingo J . HIV-1 infection alters gene expression in adipose tissue, which contributes to HIV- 1/HAART-associated lipodystrophy. Antivir Ther. 2007; 11(6):729-40. View

11.

Donkor J, Sparks L, Xie H, Smith S, Reue K . Adipose tissue lipin-1 expression is correlated with peroxisome proliferator-activated receptor alpha gene expression and insulin sensitivity in healthy young men. J Clin Endocrinol Metab. 2007; 93(1):233-9. PMC: 2190746. DOI: 10.1210/jc.2007-1535. View

12.

Wiedmann S, Fischer M, Koehler M, Neureuther K, Riegger G, Doering A . Genetic variants within the LPIN1 gene, encoding lipin, are influencing phenotypes of the metabolic syndrome in humans. Diabetes. 2007; 57(1):209-17. DOI: 10.2337/db07-0083. View

13.

Kuhn D, Martin M, Feldman D, Terry Jr A, Nuovo G, Elton T . Experimental validation of miRNA targets. Methods. 2007; 44(1):47-54. PMC: 2237914. DOI: 10.1016/j.ymeth.2007.09.005. View

14.

Calza L, Manfredi R, Chiodo F . Insulin Resistance and Diabetes Mellitus in HIV-Infected Patients Receiving Antiretroviral Therapy. Metab Syndr Relat Disord. 2008; 2(4):241-50. DOI: 10.1089/met.2004.2.241. View

15.

Koh Y, Lee M, Kim J, Kim M, Moon J, Lee Y . Lipin1 is a key factor for the maturation and maintenance of adipocytes in the regulatory network with CCAAT/enhancer-binding protein alpha and peroxisome proliferator-activated receptor gamma 2. J Biol Chem. 2008; 283(50):34896-906. PMC: 3259874. DOI: 10.1074/jbc.M804007200. View

16.

Lin Q, Gao Z, Alarcon R, Ye J, Yun Z . A role of miR-27 in the regulation of adipogenesis. FEBS J. 2009; 276(8):2348-58. PMC: 5330386. DOI: 10.1111/j.1742-4658.2009.06967.x. View

17.

Chang Y, Chang L, Chang T, Jiang Y, Lee K, Kuo S . The associations of LPIN1 gene expression in adipose tissue with metabolic phenotypes in the Chinese population. Obesity (Silver Spring). 2009; 18(1):7-12. DOI: 10.1038/oby.2009.198. View

18.

Csaki L, Reue K . Lipins: multifunctional lipid metabolism proteins. Annu Rev Nutr. 2010; 30:257-72. PMC: 3738581. DOI: 10.1146/annurev.nutr.012809.104729. View

19.

Caron-Debarle M, Boccara F, Lagathu C, Antoine B, Cervera P, Bastard J . Adipose tissue as a target of HIV-1 antiretroviral drugs. Potential consequences on metabolic regulations. Curr Pharm Des. 2010; 16(30):3352-60. DOI: 10.2174/138161210793563446. View

20.

Minami R, Yamamoto M, Takahama S, Ando H, Miyamura T, Suematsu E . Comparison of the influence of four classes of HIV antiretrovirals on adipogenic differentiation: the minimal effect of raltegravir and atazanavir. J Infect Chemother. 2010; 17(2):183-8. DOI: 10.1007/s10156-010-0101-5. View